Cel-Sci
CVM
#10574
Rank
S$43.69 M
Marketcap
S$2.48
Share price
-0.51%
Change (1 day)
-80.71%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of June 2026 : S$10.11 Million

According to Cel-Sci 's latest financial reports the company's total debt is S$10.11 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-09-30S$12.1 M-18.93%
2024-09-30S$14.93 M-19.45%
2023-09-30S$18.54 M-15.6%
2022-09-30S$21.96 M1.25%
2021-09-30S$21.69 M14.06%
2020-09-30S$19.02 M1.87%
2019-09-30S$18.67 M2.06%
2018-09-30S$18.29 M-5.25%
2017-09-30S$19.3 M8.77%
2016-09-30S$17.75 M-10.21%
2015-09-30S$19.76 M1281.41%
2014-09-30S$1.43 M0.61%
2013-09-30S$1.42 M4.83%
2012-09-30S$1.35 M-79.1%
2011-09-30S$6.49 M347.1%
2010-09-30S$1.45 M-7.35%
2009-09-30S$1.56 M445.42%
2008-09-30S$0.28 M
2005-09-30S$0 M0.56%
2004-09-30S$0 M-99.67%
2003-09-30S$1.5 M-52.14%
2002-09-30S$3.15 M5623.36%
2001-09-30S$0.05 M27.61%
2000-09-30S$0.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
S$62.78 B 620,695.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$73.37 B 725,368.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$0.21 B 2,053.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
S$1.33 M-86.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$21.60 B 213,524.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
S$1.01 B 9,937.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.74 B 7,265.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$0.44 M-95.58%๐Ÿ‡บ๐Ÿ‡ธ USA